Vitality Watch

Dossier pubmed preclinical 01-sep-2026
Animal model, organoid, or cell-culture result — not yet human

LivAge: An Online Aging Clock for Murine Transcriptomic Age Estimation.

Key claim: LivAge, a hepatic RNA-seq transcriptomic clock for healthy mice, reports higher biological age in progeroid models and lower biological age under established geroprotective genetic and dietary interventions including caloric restriction and rapamycin.

Abstract

The increase in life expectancy over the past century has been accompanied by the recognition of age as the primary risk factor for a wide range of pathologies, including cardiovascular and neurodegenerative diseases, as well as cancer. Thus, the development of interventions that slow the underlying biological processes of aging could have beneficial effects on the prevention or progression of these diseases. To evaluate such geroprotective interventions, quantifying biological damage via aging clocks-particularly those based on transcriptomic biomarkers-has become highly relevant, as they provide estimations with strong biological interpretability. However, the limited availability of transcriptomic clocks for murine experimental models has hindered the implementation of these tools in aging research and their use in evaluating interventions that may have geroprotective effects. Here, we have developed an accurate, accessible, and ready-to-use murine transcriptomic clock that provides robust age predictions for healthy mice using hepatic RNA-seq data. Applying the clock to accelerated-aging models revealed an increased transcriptomic age in progeroid syndromes, demonstrating its ability to capture aging-related biological processes. Finally, considering the main interest of these tools, we show that well-established interventions with geroprotective potential, both genetic (Snell Dwarf, Ames Dwarf, and growth hormone receptor-deficient mice) and environmental (caloric, protein, or methionine restriction, as well as rapamycin supplementation in specific contexts), reduce the transcriptomic age estimated by the clock. These findings indicate that the proposed transcriptomic clock could be a valuable tool for studying the biology of aging and for designing and evaluating potential geroprotective interventions.

Why this matters

LivAge adds an accessible, organ-specific (hepatic) transcriptomic clock to the murine preclinical toolkit, where most published clocks are epigenetic and often not deployed as usable tools. Its behavior on progeroid and geroprotective models fits the standard face-validity pattern for new clocks, but — as with every clock in this area — directional movement under CR or rapamycin is not itself proof of biological de-aging.

Source

Link

Briefing card

LivAge: An Online Aging Clock for Murine Transcriptomic Age Estimation.
Stage: preclinical · pubmed · 01-sep-2026

LivAge, a hepatic RNA-seq transcriptomic clock for healthy mice, reports higher biological age in progeroid models and lower biological age under established geroprotective genetic and dietary interventions including caloric restriction and rapamycin.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1111/acel.70677

build build 880 · 2bcef25 · 2026-11-18